Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nektar Therapeutics, Inc. Investors
LOS ANGELES--(BUSINESS WIRE)--Nov 28, 2018--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Nektar Therapeutics, Inc. (“Nektar” or the “Company”) (NASDAQ: NKTR ) investors concerning the Company and its officers’ possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
The investigation concerns whether or not Nektar complied with the federal securities law. On October 1, 2018, a report was published by Plainview LLC alleged that Nektar’s plan to develop NKTR-214 into “a new universal cancer treatment” “has never worked in practice,” and further argued that Nektar’s choice to only disclose certain trial results represented “an unprecedented level of data opacity.” On this news, Nektar’s share price fell, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased Nektar, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181128005875/en/
CONTACT: Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Glancy Prongay & Murray LLP
Copyright Business Wire 2018.
PUB: 11/28/2018 08:07 PM/DISC: 11/28/2018 08:07 PM